Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.4%

6 terminated out of 81 trials

Success Rate

88.7%

+2.1% vs benchmark

Late-Stage Pipeline

11%

9 trials in Phase 3/4

Results Transparency

19%

9 of 47 completed with results

Key Signals

9 with results89% success

Data Visualizations

Phase Distribution

68Total
Not Applicable (26)
Early P 1 (2)
P 1 (17)
P 2 (14)
P 3 (2)
P 4 (7)

Trial Status

Completed47
Unknown16
Recruiting7
Terminated6
Not Yet Recruiting3
Withdrawn1

Trial Success Rate

88.7%

Benchmark: 86.5%

Based on 47 completed trials

Clinical Trials (81)

Showing 20 of 20 trials
NCT07673484CompletedPrimary

Tattooing and Piercing Among Medical Students

NCT07679243Phase 1Not Yet RecruitingPrimary

A Clinical Study on the Safety and Efficacy of Wide-Band Ultrasound Combined With Traditional Chinese Medicine Preparations in the Prevention and Treatment of Keloids

NCT07660406Phase 1RecruitingPrimary

Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT

NCT05461157Not ApplicableEnrolling By Invitation

Preoperative Silicone Ointment and Wound Healing

NCT01619553RecruitingPrimary

Genetic Analysis of Keloids

NCT07526168Not ApplicableNot Yet RecruitingPrimary

Intralesional Cryosurgery Alone Versus Combined With 5-FU and Triamcinolone for Keloids

NCT07420166Not ApplicableCompletedPrimary

Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids

NCT04722263Not ApplicableRecruitingPrimary

Radiotherapy for Keloids

NCT07263100Not ApplicableCompleted

Comparative Study Between Intralesional Corticosteroid Injection Alone and Combined Intralesional Corticosteroid Injection With Either Long-pluse Nd YAG or Erbium Yag for Treating Hypertrophic or Keloid Scars

NCT05330078Early Phase 1CompletedPrimary

Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids

NCT06373458Phase 2RecruitingPrimary

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

NCT05128383Phase 2CompletedPrimary

Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids

NCT04988022Phase 4CompletedPrimary

Dupilumab in the Treatment of Keloids

NCT04827875Phase 1CompletedPrimary

Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

NCT03312166Not ApplicableCompletedPrimary

Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]

NCT04824612Not ApplicableCompletedPrimary

Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.

NCT06138964Phase 2RecruitingPrimary

Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars

NCT06431360Not ApplicableRecruitingPrimary

Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid

NCT01125137Not ApplicableCompletedPrimary

Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar

NCT04844840Phase 2CompletedPrimary

A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence

Scroll to load more

Research Network

Activity Timeline